Medical treatment of cholesterol gall stones aims to dissolve the ston
es leaving the biliary tract stone-free and the gall bladder in situ.
The introduction of extracorporeal shock wave lithotripsy and contact
solvent therapy with methyl tert butyl ether have revolutionised the m
edical management of both gall bladder stones and bile duct stones whi
ch are too large to be treated by sphincterotomy. Both approaches repr
esent a major advance over cheno- and ursodeoxycholic acid which are e
ffective in less than 30% of cases and require prolonged therapy. All
medical treatments require a functioning gall bladder and suffer from
relapse rates in the order of 10% per annum. Secondary prophylaxis is
expensive and the rate of compliance and long term safety have yet to
be established.